Walleye Trading
CYTK icon

Walleye Trading’s Cytokinetics CYTK Stock Holding History

Walleye Trading’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
52,600
+8,500
+19% +$610K 0.01% 1358
2026
Q1 		$2.91M Buy
44,100
+16,000
+57% +$1.02M ﹤0.01% 1463
2025
Q4 		$1.79M Sell
28,100
-3,600
-11% -$224K ﹤0.01% 1986
2025
Q3 		$1.74M Sell
31,700
-56,500
-64% -$2.33M ﹤0.01% 1903
2025
Q2 		$2.91M Buy
88,200
+87,300
+9,700% +$3.04M 0.01% 1511
2025
Q1 		$36.2K Buy
+900
New +$41.4K ﹤0.01% 3695
2024
Q2 		– Sell
-19,600
Closed -$1.37M – 4397
2024
Q1 		$1.37M Sell
19,600
-23,300
-54% -$1.8M ﹤0.01% 1990
2023
Q4 		$3.58M Buy
42,900
+2,900
+7% +$105K 0.01% 1467
2023
Q3 		$1.18M Buy
40,000
+1,800
+5% +$59.9K ﹤0.01% 2240
2023
Q2 		$1.25M Buy
+38,200
New +$1.41M ﹤0.01% 1989
2023
Q1 		– Sell
-16,400
Closed -$751K – 4923
2022
Q4 		$751K Buy
16,400
+11,900
+264% +$512K ﹤0.01% 2470
2022
Q3 		$218K Buy
4,500
+2,000
+80% +$96.3K ﹤0.01% 3601
2022
Q2 		$98K Buy
+2,500
New +$101K ﹤0.01% 4119
2022
Q1 		– Sell
-700
Closed -$32K – 5424
2021
Q4 		$32K Sell
700
-4,800
-87% -$185K ﹤0.01% 4801
2021
Q3 		$197K Buy
+5,500
New +$162K ﹤0.01% 3862

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's CYTK Position: Q2 2026 in Review

Walleye Trading opened a new position in Cytokinetics (CYTK) in Q2 2026: 2,951 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #3017 among its holdings. This is a return to the name: Walleye Trading previously reported a position in CYTK as recently as Q4 2025.

Walleye Trading first reported a position in CYTK in Q3 2015 and has held it in 12 quarters since. The position peaked at $3.45M in Q4 2023. 484 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Walleye Trading held 2,951 shares of Cytokinetics worth $251K as of Q2 2026.
  • Cytokinetics was a new Walleye Trading position in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3017 holding.
  • Walleye Trading first reported a position in Cytokinetics in Q3 2015 and has held it in 12 quarters since.
  • Walleye Trading's Cytokinetics position peaked at $3.45M in Q4 2023.
  • 484 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.